Triple
T19157577
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Animal Health |
E468963
|
entity |
| Predicate | associatedWithBrand |
P2830
|
FINISHED |
| Object | Merck Animal Health |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Merck Animal Health | Statement: [Animal Health, associatedWithBrand, Merck Animal Health]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Merck Animal Health Context triple: [Animal Health, associatedWithBrand, Merck Animal Health]
-
A.
Zoetis
Zoetis is a leading global animal health company that develops, manufactures, and markets medicines, vaccines, and diagnostic products for livestock and companion animals.
-
B.
Stada Arzneimittel
Stada Arzneimittel is a German pharmaceutical company known for producing generic and over-the-counter medicines for global markets.
-
C.
Omnicare
Omnicare is a pharmacy services company specializing in providing medications and related services to long-term care and other institutional healthcare facilities.
-
D.
Elanco (historically, before spin-off)
Elanco (historically, before its spin-off) was Eli Lilly and Company's animal health division, focused on developing and marketing veterinary pharmaceuticals and related products for livestock and companion animals.
-
E.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Merck Animal Health Target entity description: Merck Animal Health is a global biopharmaceutical company division that develops and markets veterinary medicines, vaccines, and health solutions for livestock and companion animals.
-
A.
Zoetis
Zoetis is a leading global animal health company that develops, manufactures, and markets medicines, vaccines, and diagnostic products for livestock and companion animals.
-
B.
Stada Arzneimittel
Stada Arzneimittel is a German pharmaceutical company known for producing generic and over-the-counter medicines for global markets.
-
C.
Omnicare
Omnicare is a pharmacy services company specializing in providing medications and related services to long-term care and other institutional healthcare facilities.
-
D.
Elanco (historically, before spin-off)
Elanco (historically, before its spin-off) was Eli Lilly and Company's animal health division, focused on developing and marketing veterinary pharmaceuticals and related products for livestock and companion animals.
-
E.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dd084ff48190ac0f8c46ee722629 |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5eeba91a081909c04d61d6117da06 |
completed | April 20, 2026, 9:15 a.m. |
Created at: April 10, 2026, 12:06 p.m.